Detalhe da pesquisa
1.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci
; 115(2): 540-554, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098261
2.
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).
Jpn J Clin Oncol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520037
3.
Relationship between stable cesium concentration and body size of Japanese flounder Paralichthys olivaceus and the effect of a size-dependent shift in diet.
J Fish Biol
; 104(3): 866-877, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009686
4.
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503.
Qual Life Res
; 32(9): 2629-2637, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126140
5.
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
Int J Clin Oncol
; 28(7): 872-879, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171692
6.
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Cancer Sci
; 113(3): 1002-1009, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845792
7.
A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE-BC.
Cancer
; 128(8): 1692-1698, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045185
8.
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.
Oncologist
; 27(9): 720-e702, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759340
9.
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
Future Oncol
; 18(5): 523-531, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034503
10.
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis.
Exp Cell Res
; 398(2): 112416, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307020
11.
Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life.
J Psychosoc Oncol
; 40(4): 527-540, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34266363
12.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280658
13.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955977
14.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885881
15.
Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Cancer
; 125(22): 4076-4083, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381152
16.
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
Invest New Drugs
; 37(6): 1207-1217, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790152
17.
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
Jpn J Clin Oncol
; 49(8): 749-754, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31070750
18.
Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.
Jpn J Clin Oncol
; 49(2): 165-173, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30508192
19.
A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.
Jpn J Clin Oncol
; 49(2): 121-129, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576544
20.
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
Int J Clin Oncol
; 24(12): 1543-1548, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352631